Alopecia Areata

Top drugs studied for this disease

EMA approval · 2025-03-03
EMA Authorised: Litfulo (ritlecitinib tosilate) — Pfizer Europe MA EEIG
The European Medicines Agency authorised Litfulo (ritlecitinib tosilate) from Pfizer Europe MA EEIG for the treatment of alopecia areata in …
FDA approval · 2023-06-23
FDA Approved: LITFULO — Original Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Litfulo (ritlecitinib) from Pfizer as an original application, marking the first approval of this JAK inhibitor for alopeci…